Incorporating genomics into the cancer clinical trial process

Seminars in Oncology

Volumn 28, Issue 3, 2001, Pages 305-309

  Paik, Soonmyung ^a  

^a NSABP Foundation Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RESEARCH; CLINICAL TRIAL; DISEASE MARKER; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; FEASIBILITY STUDY; HUMAN; METHODOLOGY; PHARMACOGENETICS; PREDICTION; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0034988840     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(01)90123-X     Document Type: Article

References (8)

1. Kinetic concepts in the systemic drug therapy of breast cancer
2. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
3. Differential toxicities of anticancer agents among DNA repair and check-point mutants of Saccharomyces cerevisiae
4. Use of a cDNA microarray to analyse gene expression patterns in human cancer
5. Genome-wide analysis of DNA copy-number changes using cDNA microarrays
6. Gene expression profiles of laser-captured adjacent neuronal subtypes
7. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
8. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling